Health News

New Treatment Helped More Patients Ditch Nicotine
If you can fight fire with fire, why not fight addiction to nicotine with another chemical?
FDA Drug Safety Communication: Chantix Heart Risk
The US Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix (varenicline) may be associated with a small, increased risk of certain cardiovascular adverse events in patients who have cardiovascular disease.
Label Warnings Updated for Chantix
U.S. Food and Drug Administration (FDA) officials have approved an updated drug label for smoking cessation medication varenicline (Chantix) with stronger warnings.
Chantix Linked to 72% Increase in Heart Problems
Cigarette smokers may be ready to kick their habit, but a popular smoking cessation drug may only add health risks. A new study indicates that Chantix (varenicline) may come with a heightened risk of serious heart problems.
Smoking Drug Chantix Risky for Heart Patients
U.S. Food and Drug Administration officials recently warned smokers with a history of heart disease that taking smoking cessation drug varenicline (Chantix) could could put them at added risk for a heart attack or peripheral vascular disease.
FDA: Chantix (varenicline) May Increase Cardiovascular Risk
The U.S. Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix ( varenicline ) may be associated with a small, increased risk of certain cardiovascular adverse events in patients who have cardiovascular disease.